2 completed, 1 unknown. 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow metuximab: new trials by email Literature Review of metuximab trials Research Report on metuximab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma Licartin and CIK - Multiple Drug Use | Phase 4 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 120 | 2012-01-01 | 2016-02-17 |
| Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma Licartin, Transcatheter arterial chemoembolization - Unresectable Hepatocellular Carcinoma | Phase 4 | Completed | Eastern Hepatobiliary Surgery Hospital | 400 | 2008-12-01 | 2016-04-01 |
| A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection Licartin (generic name,[131I]metuximab injection) - Hepatocellular Carcinoma | Phase 2 | Completed | Eastern Hepatobiliary Surgery Hospital | 200 | 2008-12-01 | 2016-04-01 |
Eastern Hepatobiliary Surgery Hospital (2) · Tianjin Medical University Cancer Institute and Hospital (1)
China (2)
Feng Shen, MD (1) · Yan Zhao, Doctor (1)